Company intelligence
Kayentis
Embark on a seamless eCOA clinical trial experience
About Kayentis
Kayentis, a global leader in eCOA and decentralized clinical trial solutions, empowers pharma, biotech and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in over 200 indications across more than 20 therapeutic areas. Adapting to the changing landscape, Kayentis is now offering a comprehensive suite of services to support science-driven and patient-centric clinical research, with operational capabilities across the US, Europe and Asia.
Verified activity
Signals from Kayentis
3 published signals
Presence & Recognition
Kayentis announced that Andrea Murison and Jim Tolley will be attending DPHARM 2026 in booth 306 to discuss clinical trials technologies, strategies, and innovations.
Reported by Kayentis
Presence & Recognition
Kayentis is exhibiting at Booth 306 at DPHARM 2026 in Boston.
Reported by Andrea Murison
Presence & Recognition
Kayentis will be attending the SCDM conference in Raleigh with Chris Kemper and Chris Barden.
Reported by Kayentis